66852-54-8,MFCD00866013
Catalog No.:AA00F9SV

66852-54-8 | Halobetasol propionate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥95%
in stock  
$46.00   $32.00
- +
10mg
≥95%
in stock  
$79.00   $55.00
- +
25mg
98%(HPLC)
in stock  
$107.00   $75.00
- +
50mg
in stock  
$179.00   $125.00
- +
100mg
98%(HPLC)
in stock  
$223.00   $156.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00F9SV
Chemical Name:
Halobetasol propionate
CAS Number:
66852-54-8
Molecular Formula:
C25H31ClF2O5
Molecular Weight:
484.9604
MDL Number:
MFCD00866013
SMILES:
CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F)C(=O)CCl
Properties
Computed Properties
 
Complexity:
964  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.7  

Literature

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology 20111201

Title: Disseminated porokeratosis of Mibelli: A case report.

Journal: Dermatology online journal 20101215

Title: The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.

Journal: Journal of drugs in dermatology : JDD 20090801

Title: Halobetasol versus clobetasol: a study of potency.

Journal: Indian journal of dermatology, venereology and leprology 20090101

Title: Astrocyte response to Junín virus infection.

Journal: Neuroscience letters 20081107

Title: A degradation product of halobetasol propionate: characterization and structure.

Journal: Steroids 20071001

Title: Vexing vesicles.

Journal: The American journal of medicine 20070701

Title: Sebaceous hyperplasia of the vulva: case report and review of the literature.

Journal: Journal of lower genital tract disease 20060101

Title: Ultrapotent topical corticosteroid treatment of hemangiomas of infancy.

Journal: Journal of the American Academy of Dermatology 20050201

Title: Topical halobetasol propionate in the treatment of plaque psoriasis: a review.

Journal: American journal of clinical dermatology 20050101

Title: Nevoid hyperkeratosis of the nipple and/or areola: a report of two cases and a review of the literature.

Journal: International journal of dermatology 20021101

Title: Vitamin D and topical therapy.

Journal: Cutis 20021101

Title: Spectrophotometric determination of clobetasol propionate, halobetasol propionate, quinagolide hydrochloride, through charge transfer complexation.

Journal: Journal of pharmaceutical and biomedical analysis 20020301

Title: Treating psoriasis in primary care settings. Preserving quality of life is a primary--and possible--goal.

Journal: Advance for nurse practitioners 20011201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:66852-54-8 Molecular Formula|66852-54-8 MDL|66852-54-8 SMILES|66852-54-8 Halobetasol propionate
Catalog No.: AA00F9SV
66852-54-8,MFCD00866013
66852-54-8 | Halobetasol propionate
Pack Size: 5mg
Purity: ≥95%
in stock
$46.00 $32.00
Pack Size: 10mg
Purity: ≥95%
in stock
$79.00 $55.00
Pack Size: 25mg
Purity: 98%(HPLC)
in stock
$107.00 $75.00
Pack Size: 50mg
Purity:
in stock
$179.00 $125.00
Pack Size: 100mg
Purity: 98%(HPLC)
in stock
$223.00 $156.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00F9SV
Chemical Name: Halobetasol propionate
CAS Number: 66852-54-8
Molecular Formula: C25H31ClF2O5
Molecular Weight: 484.9604
MDL Number: MFCD00866013
SMILES: CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F)C(=O)CCl
Properties
Complexity: 964  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 9  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 33  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.7  
Literature fold

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology20111201

Title: Disseminated porokeratosis of Mibelli: A case report.

Journal: Dermatology online journal20101215

Title: The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.

Journal: Journal of drugs in dermatology : JDD20090801

Title: Halobetasol versus clobetasol: a study of potency.

Journal: Indian journal of dermatology, venereology and leprology20090101

Title: Astrocyte response to Junín virus infection.

Journal: Neuroscience letters20081107

Title: A degradation product of halobetasol propionate: characterization and structure.

Journal: Steroids20071001

Title: Vexing vesicles.

Journal: The American journal of medicine20070701

Title: Sebaceous hyperplasia of the vulva: case report and review of the literature.

Journal: Journal of lower genital tract disease20060101

Title: Ultrapotent topical corticosteroid treatment of hemangiomas of infancy.

Journal: Journal of the American Academy of Dermatology20050201

Title: Topical halobetasol propionate in the treatment of plaque psoriasis: a review.

Journal: American journal of clinical dermatology20050101

Title: Nevoid hyperkeratosis of the nipple and/or areola: a report of two cases and a review of the literature.

Journal: International journal of dermatology20021101

Title: Vitamin D and topical therapy.

Journal: Cutis20021101

Title: Spectrophotometric determination of clobetasol propionate, halobetasol propionate, quinagolide hydrochloride, through charge transfer complexation.

Journal: Journal of pharmaceutical and biomedical analysis20020301

Title: Treating psoriasis in primary care settings. Preserving quality of life is a primary--and possible--goal.

Journal: Advance for nurse practitioners20011201

Building Blocks More >
6698-26-6
6698-26-6
2',5'-DIDEOXYADENOSINE
AA00FA54 | MFCD00210904
676371-00-9
676371-00-9
6-Bromoimidazo[1,2-a]pyridin-8-amine
AA00FAD2 | MFCD08273920
6582-22-5
6582-22-5
2-(4-Methylphenyl)-2-phenylethylamine, HCl
AA00FAJN | MFCD02089464
66346-83-6
66346-83-6
6-Chloropyridazine-3-carboxamide
AA00FAPI | MFCD09258882
66009-35-6
66009-35-6
H-Tyr(bzl)-obzl p-tosylate
AA00FAWA | MFCD00077105
72963-77-0
72963-77-0
1-DEOXYFORSKOLIN
AA00FB4B | MFCD09763710
7473-36-1
7473-36-1
Ethyl beta-d-thioglucoside
AA00FBDQ | MFCD09836206
73962-07-9
73962-07-9
ETHYL-D5 CARBAMATE
AA00FBKV | MFCD00190444
68454-18-2
68454-18-2
4-Methyl-7-(2-oxopropoxy)-2h-chromen-2-one
AA00FBQV | MFCD00848918
677331-12-3
677331-12-3
iCRT 14
AA00FBX9 | MFCD04366833
Submit
© 2017 AA BLOCKS, INC. All rights reserved.